GRI Bio, Inc.【GRI】
Market cap
$229.07K
P/E ratio
| Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Research and development | 5 | 1 | 3 | 4 |
| General and administrative | 4 | 6 | 8 | 4 |
| Total operating expenses | 9 | 7 | 11 | 8 |
| Loss from operations | -9 | -7 | -11 | -8 |
| Other income | 0 | - | 0 | - |
| Change in fair value of warrant liability | - | - | 0 | 0 |
| Interest income (expense), net | -0 | 0 | -2 | 0 |
| Net loss | -9 | -7 | -13 | -8 |
| Deemed dividend on Series B Warrants | - | - | - | 2 |
| Net loss available to common stockholders | - | - | - | -10 |
| Earnings Per Share, Basic | -1.42 | -0.69 | -28.25 | -55.21 |
| Earnings Per Share, Diluted | -1.42 | -0.69 | -28.25 | -55.21 |